Abbott Laboratories - 36 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of September 17, 2019 is 83.58.
- The all-time high Abbott Laboratories stock closing price was 88.74 on July 23, 2019.
- The Abbott Laboratories 52-week high stock price is 88.76, which is 6.2% above the current share price.
- The Abbott Laboratories 52-week low stock price is 65.44, which is 21.7% below the current share price.
- The average Abbott Laboratories stock price for the last 52 weeks is 76.74.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 79.2665 | 69.5000 | 88.7400 | 66.2200 | 83.5800 | 15.55% |
| 2018 | 64.2198 | 58.7900 | 74.2700 | 56.2700 | 72.3300 | 26.74% |
| 2017 | 48.5437 | 39.0500 | 57.4700 | 39.0500 | 57.0700 | 48.58% |
| 2016 | 40.4946 | 42.9300 | 45.2900 | 36.3400 | 38.4100 | -14.47% |
| 2015 | 46.3063 | 44.9000 | 51.2000 | 39.0600 | 44.9100 | -0.24% |
| 2014 | 40.9592 | 38.2300 | 46.3700 | 35.8500 | 45.0200 | 17.45% |
| 2013 | 35.6540 | 32.0500 | 38.7100 | 32.0500 | 38.3300 | -41.48% |
| 2012 | 62.7592 | 56.7200 | 72.1300 | 54.1500 | 65.5000 | 16.49% |
| 2011 | 51.0656 | 47.8200 | 56.3300 | 45.1600 | 56.2300 | 17.37% |
| 2010 | 50.7320 | 54.4600 | 56.2400 | 45.8600 | 47.9100 | -11.26% |
| 2009 | 48.4288 | 53.5600 | 57.2500 | 41.5200 | 53.9900 | 1.16% |
| 2008 | 55.1625 | 55.8100 | 60.5000 | 49.4500 | 53.3700 | -4.95% |
| 2007 | 54.4193 | 48.9700 | 59.4300 | 48.9700 | 56.1500 | 15.27% |
| 2006 | 45.0284 | 39.5500 | 49.4800 | 39.5500 | 48.7100 | 23.54% |
| 2005 | 45.3700 | 46.6700 | 49.9900 | 37.6300 | 39.4300 | -15.48% |
| 2004 | 42.3562 | 46.7500 | 46.9900 | 38.3600 | 46.6500 | 0.11% |
| 2003 | 41.2727 | 40.0500 | 47.1500 | 34.3800 | 46.6000 | 16.50% |
| 2002 | 45.8684 | 55.8400 | 57.7000 | 31.0000 | 40.0000 | -28.25% |
| 2001 | 50.0663 | 48.1300 | 56.7700 | 42.0600 | 55.7500 | 15.09% |
| 2000 | 41.6982 | 35.0000 | 55.7500 | 29.6300 | 48.4400 | 33.41% |
| 1999 | 43.6333 | 48.7500 | 52.9400 | 33.3100 | 36.3100 | -25.90% |
| 1998 | 40.9077 | 33.7200 | 49.7500 | 33.3450 | 49.0000 | 49.62% |
| 1997 | 30.8148 | 25.1900 | 34.3150 | 25.1900 | 32.7500 | 29.06% |
| 1996 | 22.6483 | 20.8750 | 28.3750 | 19.3750 | 25.3750 | 21.91% |
| 1995 | 19.2416 | 16.3150 | 22.3150 | 15.6250 | 20.8150 | 27.58% |
| 1994 | 14.8357 | 14.4400 | 16.8150 | 13.0650 | 16.3150 | 10.12% |
| 1993 | 13.4211 | 15.1900 | 15.1900 | 11.5000 | 14.8150 | -2.47% |
| 1992 | 15.3475 | 16.8125 | 17.0300 | 13.5000 | 15.1900 | -11.78% |
| 1991 | 13.0176 | 10.8125 | 17.2175 | 9.9375 | 17.2175 | 53.04% |
| 1990 | 9.5320 | 8.6563 | 11.3750 | 7.8750 | 11.2500 | 32.35% |
| 1989 | 7.3855 | 5.9688 | 8.7663 | 5.8288 | 8.5000 | 41.28% |
| 1988 | 5.8545 | 6.0788 | 6.5000 | 5.3750 | 6.0163 | -0.25% |
| 1987 | 7.1870 | 5.9375 | 8.3600 | 5.3750 | 6.0313 | 5.74% |
| 1986 | 5.4847 | 4.2500 | 6.7963 | 3.9844 | 5.7038 | 33.48% |
| 1985 | 3.4075 | 2.5394 | 4.3831 | 2.5000 | 4.2731 | 63.76% |
| 1984 | 2.6840 | 2.8750 | 3.0000 | 2.3750 | 2.6094 | -7.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $148.939B | $30.578B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $147.141B | 20.65 |
| Stryker (SYK) | United States | $81.622B | 28.23 |
| Boston Scientific (BSX) | United States | $58.240B | 28.25 |
| Baxter (BAX) | United States | $44.383B | 26.91 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $31.497B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.496B | 18.24 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.271B | 0.00 |
| Coloplast (CLPBY) | Denmark | $24.948B | 39.83 |
| Terumo (TRUMY) | Japan | $22.330B | 25.68 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.407B | 0.00 |
| ResMed (RMD) | United States | $18.992B | 36.22 |
| Sunny Optical Technology (SNPTF) | China | $16.672B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.967B | 53.43 |
| Canopy Growth (CGC) | Canada | $9.552B | 0.00 |
| Insulet (PODD) | United States | $8.633B | 511.57 |
| Perrigo (PRGO) | Ireland | $7.614B | 14.02 |
| William Demant Holdings (WILYY) | Denmark | $7.386B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.024B | 20.94 |
| Haemonetics (HAE) | United States | $6.359B | 47.99 |
| Aurora Cannabis (ACB) | Canada | $6.071B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.570B | 28.78 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.356B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| Neogen (NEOG) | United States | $4.116B | 68.33 |
| NuVasive (NUVA) | United States | $3.380B | 26.95 |
| ICU Medical (ICUI) | United States | $3.364B | 21.82 |
| Hutchison China MediTech (HCM) | China | $2.903B | 0.00 |
| Quidel (QDEL) | United States | $2.783B | 27.64 |
| National Vision Holdings (EYE) | United States | $2.407B | 51.95 |
| Agios Pharmaceuticals (AGIO) | United States | $2.217B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.794B | 0.00 |
| Aphria (APHA) | $1.687B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.129B | 26.01 |
| AtriCure (ATRC) | United States | $0.989B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.956B | 25.12 |
| Omeros (OMER) | United States | $0.915B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.866B | 14.08 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.787B | 20.07 |
| NanoString Technologies (NSTG) | United States | $0.774B | 0.00 |
| PetIQ (PETQ) | United States | $0.751B | 17.74 |
| Cerus (CERS) | United States | $0.747B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.705B | 41.80 |
| Quanterix (QTRX) | United States | $0.654B | 0.00 |
| MacroGenics (MGNX) | United States | $0.640B | 0.00 |
| Surmodics (SRDX) | United States | $0.632B | 120.08 |
| TG Therapeutics (TGTX) | United States | $0.614B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.468B | 21.69 |
| Meridian Bioscience (VIVO) | United States | $0.422B | 13.16 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.409B | 0.00 |
| Owens & Minor (OMI) | United States | $0.394B | 11.81 |
| BioLife Solutions (BLFS) | United States | $0.385B | 126.69 |
| Utah Medical Products (UTMD) | United States | $0.369B | 27.00 |
| United Health Products (UEEC) | United States | $0.325B | 0.00 |
| Zynex (ZYXI) | United States | $0.292B | 31.03 |
| Bovie Medical (APYX) | United States | $0.256B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.197B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.177B | 0.00 |
| Vapotherm (VAPO) | United States | $0.159B | 0.00 |
| Fonar (FONR) | United States | $0.157B | 11.17 |
| Chimerix (CMRX) | United States | $0.135B | 0.00 |
| Female Health (VERU) | United States | $0.124B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.118B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.106B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 20.72 |
| MRI Interventions (MRIC) | United States | $0.065B | 0.00 |
| Nephros (NEPH) | United States | $0.058B | 0.00 |
| Surface Oncology (SURF) | United States | $0.058B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.031B | 0.00 |
| Senestech (SNES) | United States | $0.025B | 0.00 |
| Myomo (MYO) | United States | $0.014B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.010B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.009B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
